Principal Investigator James Collins
In response to new business models, accelerated timelines, and unforeseen market dynamics, healthcare companies are seeking to innovate rapidly and effectively to meet new challenges. A key criterion for success is the adoption of cutting-edge tools that derisk and accelerate the drug development process. Investment in these tools pays dividends across a company's pipeline.
Principal Investigator Vinod Vaikuntanathan
Tancredi Botto Co-Founder and CEO, Muon Vision
Tancredi Botto presented how muon radiography, a safe and innovative imaging technology using naturally occurring cosmic ray particles, drove a step change in the efficiency and sustainability of heap leaching operations. This technique enabled precise, quantitative 3D mapping of fluid and air content within leaching heaps over time, overcoming traditional field measurement challenges. These insights were critical for optimizing metal yields, reducing operational costs, and managing geotechnical risks at scale.
Principal Investigator Shiladitya Sengupta